Senior Manager, Competitive Intelligence - 4D Molecular Therapeutics
Emeryville, CA
About the Job
Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. Agencies must be expressly engaged by the 4DMT Talent Acquisition team on any requisition. Agencies reaching out directly to hiring managers will not be tolerated and doing so may impact your ability to work with 4DMT in the future.
4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products. We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.
We have built a deep portfolio of AVV-based gene therapy product candidates, with five product candidates in clinical trials: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease, 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, we have two product candidates in preclinical studies: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency.
To-date, we have demonstrated clinical proof-of-concept for three evolved vectors in three therapeutic areas and routes of administration with five products and patient populations. We believe this validates the power of our directed evolution platform for discovering superior vectors compared to wildtype viral vectors. We have built a robust and efficient product engine with 6 open Investigational New Drug Applications (INDs) in the U.S., 1 IND in Taiwan, and 1 Clinical Trial Approval (CTA) in Australia. We believe we are positioned to create, develop, manufacture and, if approved, effectively commercialize targeted genetic medicines that could transform the lives of patients suffering from debilitating diseases.
In addition to TVE, our technology includes a robust AAV manufacturing platform and onsite manufacturing facility that allows us to rapidly produce and test research grade material and scale up to GMP clinical material. This internal capability and close collaboration between our R&D and Manufacturing teams has greatly accelerated the pace of discovery at 4DMT.
Company Differentiators:
• Fully integrated clinical-phase company with internal manufacturing
• Demonstrated ability to move rapidly from idea to IND
• Five candidate products in the clinic and two declared pre-clinical programs
• Robust technology and IP foundation, including our TVE and manufacturing platforms
• Initial product safety and efficacy data substantiates the value of our platforms
• Opportunities to expand to other indications and modalities within genetic medicine
General Summary
The Senior Manager of Competitive Intelligence is a key contributor to competitive planning efforts that shape the company’s commercial and development strategies. This individual will be a crucial strategic thought partner to key internal stakeholders throughout the organization. This individual will be responsible for leading and managing primary and secondary competitive intelligence activities and will work closely with multiple cross-functional teams. This individual will also lead and support strategy analyses in support of cross-functional teams including commercial, clinical, IR and business development.
RESPONSIBILITIES:
Competitive Intelligence: 70% of TIME
- Define and lead CI processes that meet the evolving needs of cross-functional stakeholders. Proactively anticipate competitive milestones and evolving industry dynamics.
- Organize CI activities, including scoping and overseeing vendor support as appropriate.
- Lead planning for key industry, medical, and broker conferences
- Define yearly schedule and drive working team preparedness
- Attend key scientific congresses and summarize key insights from a scientific perspective focusing on novel treatment paradigms, mechanisms of action, and clinical trial landscape.
- Communicates conference coverage insights (oversees which meetings to attend, which presentations to flag, drives CI writeups)
- Cover competitor earnings and key investor calls, providing summaries of key metrics and implications in a timely manner
- Consistently and effectively communicates with key stakeholders to inform on timely alerts (e.g. clinical data releases, product approvals/failures) and landscape updates with commercial implications
- Develop and maintain accessible competitive summaries and analyses across the portfolio
- Lead and manage the collection and analysis of information from other teams at 4DMT (Clinical, IR)
- Proactively anticipate cross-functional needs
- Take the initiative to partner with peers across business functions to gather and analyze data
- Achieve visibility across teams within the company
- Generate reports, dashboards and analyses for company executives to support strategic decision making, including portfolio and pipeline management and business development activities
Strategy Analysis: 30% of TIME
- Support insight generation and competitive scenarios to aid with forecast models and strategic plans, including risks and opportunities, and alternate scenarios
- Research relevant and emerging technologies of interest and understanding the impact on our business
- Translate data and information into compelling insights and recommendations. Effectively communicate insights and lead meetings with commercial leaders and other cross functional business partners
- Lead and support analytics required to generate and triangulate insights across data sources, including primary market research, secondary literature and other data sources, as available
- Other duties as assigned, nothing in this job description restricts management’s right to assign or reassign duties and responsibilities to this job at any time
QUALIFICATIONS:
Education:
- Advanced degree in a relevant life science discipline.
Experience:
- Minimum of 2-3 years work experience, preferably with specific biopharma competitive intelligence responsibilities and/or with a life science consulting firm.
- Demonstrated understanding of the pharmaceutical product development lifecycle
- Prior knowledge about the workings of clinical trials
- Understanding of biotech market
- Knowledge of biology behind disease manifestations
- Demonstrated excellence in communication as related to writing, analysis and presentation
- Experience with primary intelligence and secondary data sources is highly desirable
- Expertise in ophthalmology and/or gene therapy is preferred
Skills
- Advanced or Expert level in Microsoft Office: Excel, Powerpoint, Word, Outlook
- Qualitative and quantitative databases and analysis
- Project oriented (have full autonomy over specific topics and job duties)
- Analytical mindset
- Growth mindset, flexible to take on new assignments in a dynamic environment
Base salary compensation range:
Bay Area Range: $150,000/yr - $190,000/yr
National Range: $131,000/yr - $167,000/yr
Please note that compensation varies based on a variety of factors including experience, location, etc.
4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws. Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities